Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AMNION”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources

Haemophilus influenzae amnionitis associated with prematurity and premature membrane rupture.

Prematurity and premature rupture of the membranes present major obstetric problems. When associated with amnionitis, the result may be disastrous. A case of Haemophilus influenzae aminionitis in association with premature rupture of the membranes is presented. The rarity of this organism as a causative agent in amnionitis and its possible causative role in premature membrane rupture are considered in review of the scant relevant literature.

Adult↗

Effect of glycosaminoglycans and enzymes on the integrity of human placental amnion as a barrier to cell invasion.

The effects of glycosaminoglycans and several enzymes on the integrity of the human placental amnion and the consequent effects on the permeability of this structure to virally transformed cells and their parent line were examined. Treatment of the amnion with hyaluronate, heparin, and chondroitin ABC lyase affected the structure of both the epithelium and the extracellular matrix and resulted in a significant increase in tumor cell invasion, but it had no significant effect on the invasion of the parent cell line. These polymers promoted the disorganization of the epithelial cell layer, and their presence resulted both in the matting of collagen fibrils in the stroma and in the loosening of the basement membrane. Pronase treatment removed epithelial cells and stripped collagen fibrils of granules, but it did not promote tumor or parent cell invasion, perhaps as a result of loss of attachment factors. Chondroitin sulfate did not affect the epithelial structure or the rate of tumor invasion and had only slight effects on the structure of the basement membrane and the stroma. These results are consistent with the thesis that the continuity of epithelium is critical to resisting tumor cell invasion and suggest that glycosaminoglycans, in addition to certain enzymes, can alter this integrity.

Amnion↗

Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.

The ability of B16-F10 mouse melanoma cells to cross an amnion basement membrane was determined in the presence of strong inhibitors of both serine and cysteine proteases. The concentrations of inhibitors were at orders of magnitude higher than their Ki values to serine and cysteine proteases implicated in metastasis, thus ensuring a complete inhibition for tumor secreted proteases such as cathepsin B-like proteases, plasminogen activators, and plasmin. Under these conditions of high serine and cysteine protease inhibitor concentrations, no significant decrease in B16-F10 melanoma cell invasion through the amnion was observed. Separate experiments showed that the inhibitors were neither toxic to the cells nor degraded. The results show that neither tumor cell secreted cathepsin B-like proteases nor plasminogen activator have a controlling role in basement membrane crossing in this metastatic model. A possible role for tumor cell membrane proteases in basement membrane invasion, in which the substrates of the protease bind to receptor sites near a membrane associated proteolytic activity, is not eliminated.

Amnion↗

Implications for the use of amnion and chorion in podiatric medicine and surgery.

The purpose of this article is to show the possibility of using fetal membranes as a biologic dressing for some of the pedal ulcerations that podiatrists encounter. There are as many treatment modalities for lower extremity ulcerations as there are types of ulcers. Through the following case histories, the authors demonstrate various types of ulcerations treated with amnion and chorion and the results achieved. The clinical application of fetal membranes has been under study for many years. The authors' efforts support the use of amnion and chorion by the medical community in treating some lower extremity ulcers.

Adult↗

The cerebral malformation of the amnionic band syndrome.

The Amnionic Band Syndrome is a not uncommon disorder of the fetus which may result in cerebral malformations that mimic anencephaly. It is important to distinguish these two entities because of differences in pathogenesis and risk of recurrence. A preliminary stillborn female of 29 weeks gestation with multiple anomalies, including cerebral-placental fusion, cranial agenesis, cleft lip, syndactyly and ectopic liver is presented. These malformations are typical of the Amnionic Band Syndrome, an entity which has not been described in the neurologic literature.

Abnormalities, Multiple↗

Purification and characterization of a lysophospholipase from human amnionic membranes.

We have identified the presence of a lysophospholipase in human placental tissues and have purified this enzyme from the amnion. The specific activity was highest in the amnion and decreased across adjacent tissues. The purification involved the use of DEAE-Sephadex, phenyl-Sepharose, hydroxylapatite, and sulfylpropyl Sephadex chromatography. The activity of the purified enzyme toward palmitoyl lysophosphatidylcholine is 2.5 mumol min-1 mg-1 and the pH optimum is 7.0. The enzyme is not inhibited by EDTA and does not appear to have a metal ion requirement. The enzyme may be of membrane origin; the purified enzyme requires the presence of detergent during storage. The effects of substrate composition and physical state on enzymatic activity were explored. The enzyme was not active toward mono-, di-, or triglycerides, nor toward diacyl phospholipid. The enzyme was active toward myristoyl and palmitoyl lysophosphatidylcholine at concentrations where these substrates spontaneously form micelles or where Triton X-100 was used to induce co-micellization of the substrate at low concentrations with detergent. A role for this enzyme in processing the lysophospholipid product of phospholipase A action must be considered in evaluating arachidonic acid production in human fetal membranes and placental tissue, particularly during the initiation of labor.

Amnion↗

Oligohydramnios and fatal pulmonary hypoplasia without amnion nodosum.

Two cases of fatal pulmonary hypoplasia associated with hydrorrhea gravidarum are presented. Amnion nodosum was present in one case but not the other. The pathogenesis of amnion nodosum is reviewed, and the clinical implications of this pathologic finding are discussed in relation to whether the underlying pathology is renal agenesis or amniorrhea.

Amnion↗

[Myofibroblasts in connective tissue of the human amnion].

Connective tissue of the human amnion at 14, 19, 21 and 33 weeks of gestation and at full term was examined by electron microscopy. Myofibroblasts which have not been described in the amnion so far were identified in addition to fibroblasts and macrophages (Hofbauer cells). Myofibroblasts display the following morphological characteristics: 1. The nuclei have multiple indentations and deep folds. 2. Numerous bundls of filaments (5 nm and 10 nm in diameter) are present within the cytoplasm. The bundles of 5 nm-filaments contain dense bodies. 3. Frequently they are connected to each other by desmosomes or by gap junctions. 4. The plasma membrane shows many hemidesmosome-like zones of thickening. 5. The cell surface is partly covered by basement membrane. Since these cells possess the ability of contraction, we suggest that they may contribute to the protection of the amniontic membrane from overdistension.

Amnion↗

Developmental changes in the mouse amnion: a SEM study.

Both surfaces of the mouse amnion from 13 to 21 days of gestation were studied by scanning electron microscopy (SEM). The exocoelomic surface is covered by mesenchymal cells and randomly arranged fine fibers at 13 days. By 21 days, these cells are covered by thick fibers frequently arranged in woven pattern. The ectodermal lining of the amniotic cavity at 13 days is characterized by squamous epithelial cells with central patches of short microvilli. An apparent increase in microvilli occurs by 16 days followed by either the loss of microvilli or the formation of microridges by 21 days. These changes may reflect functional changes of the amnion or processes of cell aging.

Amnion↗

[Use of amnion to repair a dural defect].

Amnion stored in a LIPK-s solution is recommended for airtight closure of a defect in the dura mater in infants and young children. It may also be used in adults. Animal experiments showed that the edges of the graft placed with the inner (fetal) surface on the brain grow tightly into the dura mater along the margins of the defect with no inflammatory changes or any coarse cicatrization even in injury to the cortex. Plastic surgery of the dura mater with the amnion was carried out in the clinic in 16 children from 4 months to 7 years of age with severe and moderately severe craniocerebral trauma. No complications developed after the operation. The follow-up period is more than 5 years.

Amnion↗

Frozen preservation of human amnion and its use as a burn wound dressing.

A method of freezing and sterilizing the human amnion enabled it to be stored at -60 degrees C for more than six months. The membranes were obtained from twenty-four cesarean section mothers without a history of endometritis, premature rupture of their membranes or a positive serology. The elongation and break strength of the membranes were evaluated before and after storage. The membranes as prepared have been utilized on twenty-two wounds of ten burn patients. The results indicate that amnion is quite safe and effective as a biological dressing using this preservation method.

Adult↗

Phospholipase D activity of human amnion cells stimulated with phorbol ester and bradykinin.

We investigated the activity of phospholipase D (PLD) in human amnion cells labeled with [3H]oleate. The PLD activity was detected as signal-induced synthesis of phosphatidic acid (PA) and in the presence of ethanol, phosphatidylethanol (PEt). The PLD was shown to be activated by phorbol, 12-myristate, 13-acetate (PMA), calcium ionophore A23187, oxytocin, bombesin and bradykinin, but not by platelet-activating factor (PAF) and epidermal growth factor (EGF). The amniotic PLD thus appeared to be activated by a variety of agonists but with a certain specificity to stimulators. We examined the mode of the PLD activation using PMA (20 nM) and bradykinin (1 microM) as model stimulators. PMA and bradykinin elicited a rapid and sustained response with the peaks of PA-labeling attained at 5 and < 1 min after stimulation, respectively. In both cases, there was a concomitant rise of diacylglycerol (DG), and the PA accumulation was suppressed by ethanol at the expense of labeling of PEt. The PA synthesis caused by the two stimulators was similarly inhibited by staurosporine and by a chronic treatment with PMA (100 nM for 24 h), suggesting that the activation of PLD is linked to the action of protein kinase C. With the cells labeled with radioactive choline and ethanolamine, we found that the amniotic PLD hydrolyzed almost equally phosphatidylcholine and phosphatidylethanolamine. Although bradykinin and PMA stimulated cellular PLD to a comparable extent, prostaglandin (PG)E2 release was not stimulated by bradykinin in contrast to the marked effect by PMA. Further work is thus needed to clarify the significance of the novel PLD signaling pathway in the function of amnion cells.

Amnion↗

Arginine vasopressin-induced changes in blood flow to the ovine chorion, amnion, and placenta across gestation.

OBJECTIVES: To determine whether physiological increases in fetal plasma arginine vasopressin (AVP) concentration alter blood flow rates to the ovine chorion, amnion or placenta, and to determine whether these AVP-induced changes in flow are dependent on gestational age. METHODS: Colored microspheres (15.10 +/- 0.02 microns (standard deviation) were infused into the superior vena cava before and at 30, 75, and 125 minutes of an intravenous AVP infusion (3 ng/min/kg) in 9 chronically catheterized fetal sheep between 103 days to 141 days gestation (term = 147 days). Chorion, amnion, and placental cotyledons were removed, and microspheres were counted to determine blood flow rates. RESULTS: Fetal arterial pressure (FAP) increased (analysis of variance, P < .0001) and heart rate (FHR) decreased (P < .0001) during the infusion, with responses greater in older (> 125 days) compared to younger (< 125 days) fetuses (P < .001). Chorionic blood flow rate increased by 19 +/- 7% at 30 min of the AVP infusion, and declined by 18 +/- 6% at 75 min, and 32 +/- 5% at 125 min (P < .0001). Similarly, fetal placental blood flow rate increased by 20 +/- 7% at 30 min of infusion, and declined, in parallel with chorionic blood flow rates, by 6 +/- 4% at 75 min, and 17 +/- 4% at 125 min (P < .0001). Amniotic blood flow rate did not change significantly during the infusion. The membranous and placental blood flow rate responses to AVP infusion did not depend upon gestational age. CONCLUSIONS: Physiologic increases in plasma AVP concentration induce an early increase in chorionic blood flow followed by a gradual decrease which parallels similar changes in placental blood flow rate. Unlike FAP and FHR, these blood flow changes are not gestational age-dependent. AVP-induced blood flow changes could play an important role in determining abnormalities of amniotic fluid volume observed clinically in some stressed fetuses.

Amnion↗

ADAM sequence and innocent amniotic band: manifestations of early amnion rupture.

Thirteen placentas with early amnion rupture (EAR) are described. These placentas were characterized by the absence of amniotic epithelium on the fetal surface, presence of a slightly fibrotic small amniotic band (remnant) attaching to the umbilical cord at the placental end, and the presence of degenerated vernix squamous cells in the fibrous stroma of chorion and amnion. Eight fetuses had ADAM sequence. Six of these fetuses were miscarried between 16 and 28 weeks of gestation. Two affected infants were born alive at gestational ages of 29 and 39 weeks. Five infants were spared by ADAM sequence; two had the umbilical cord strangulated by an amniotic band and were delivered at 27 and 37 weeks. In the 3 infants unassociated with ADAM sequence or strangulation of the umbilical cord, their placentas were interpreted as having innocent amniotic band (IAB) and they were delivered between 32 and 40 weeks. The findings in this study support Torpin's hypothesis that ADAM sequence is a complication of EAR. This ADAM sequence due to simple EAR must be separated from the limb body wall malformation complex because visceral anomalies are uncommon in the former condition but are frequently seen in the latter. In this study the placental pathology of EAR was helpful in confirming the ADAM sequence in the fetus.

Abnormalities, Multiple↗

Case of complex craniofacial anomalies, bilateral nasal proboscides, palatal pituitary, upper limbs reduction, and amnion rupture sequence: disorganization phenotype?

We report a case of a dizygotic twin with complex abnormalities of head, body, and limbs. The anomalies include the following: lateral and midline cleft upper lip, ectopic palatal pituitary, natal teeth, bilateral nasal proboscides with an absent nose, left microphthalmia with conjunctival-lined cyst, right ocular dysgenesis, bilateral retinal dysplasia, platybasia with skull asymmetry, hydrocephalus secondary to aqueductal atresia, brain hemispheric asymmetry with a parietal-occipital cortical flap, agenesis of posterior corpus callosum, absence of the olfactory nerves and left anterior cerebral artery, leptomeningeal and intraventricular heterotopias, right radial longitudinal terminal meromelia with constriction rings of fingers, partial syndactyly of the third and fourth left fingers, dorsiflexed great toes and pes equinovarus bilaterally, and multiple skin tags with a sacral appendage. Additionally, this twin's placental disc and extraplacental membranes were devoid of amnion. We regard these anomalies as a possible expression of the human homologue of the disorganization phenotype or another gene mutation. Nevertheless, an abnormality of blastogenesis with early damage to organizing tissues of the frontonasal region and limbs, or a vascular disruption, cannot be excluded. Early amnion rupture sequence (possible extraamniotic pregnancy with amniotic bands, limb reduction defects with Streeter bands, and multiple skin tags tapering into amniotic bands) was also present in this case, and may have acted as a contributing factor.

Abnormalities, Multiple↗

Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture.

OBJECTIVE: Our purpose was to determine whether maternal administration of prophylactic ampicillin or erythromycin after preterm amnion rupture is associated with maternal or neonatal benefits. STUDY DESIGN: Women with singleton pregnancies between 24 and 33 weeks 6 days of gestation were eligible if they had no immediate indication for delivery. After giving informed consent, patients were randomized either to receive ampicillin (erythromycin if penicillin allergic) until delivery or to enter a control group. Women whose cervical cultures were positive for either group B streptococci or Neisseria gonorrhoeae received treatment. Tocolytics and corticosteroids were not used. RESULTS: From January 1990 to February 1992 117 patients (antibiotics 59, control 58) were recruited and analyzed. Prophylactic antibiotics were associated with a longer latent phase (mean 12 vs 7.0 days, p = 0.004) and fewer maternal infectious complications (29% vs 60%, p = 0.001). A higher incidence of neonatal necrotizing enterocolitis was observed in the treatment group (14% vs 3.5%, p = 0.05). Other neonatal complications, including death, were lower in the treatment group, but none attained statistical significance (p = 0.09 to 0.33). CONCLUSION: The use of prophylactic antibiotics in selected patients after preterm amnion rupture appears to have a demonstrable maternal benefit. Large, multicenter trials may demonstrate a significant neonatal benefit or confirm any adverse outcomes.

Adult↗

Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.

Cysteine proteinases that initiate coagulation in the absence of factor VII have been isolated from rabbit V2 carcinoma and from human amnion-chorion. Many of their biochemical properties, including a molecular weight of 68 000 and inhibition by iodoacetamide and mercury, are the same. In the paper we compare the isoelectric point, the amino acid composition and the carbohydrate content of human amnion-chorion procoagulant and cancer procoagulant. With the exception of minor differences in the amino acid composition, attributable in part to differences in species, the two proteins are closely homologous.

Amino Acids↗

Benefits of maternal corticosteroid therapy in infants weighing </=1000 grams at birth after preterm rupture of the amnion.

OBJECTIVE: The aim of the study was to determine the effects of antenatal maternal corticosteroid treatment on selected neonatal outcomes in infants weighing </=1000 g at birth after preterm rupture of membranes. STUDY DESIGN: In a 1-year (1992-1993) prospective observational study, the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network collected outcome data for 766 infants who did not have a major fetal anomaly and who had a birth weight </=1000 g (378 were born after preterm rupture of membranes). Only fetuses deemed potentially viable by the obstetrician were included in our analysis. Selected neonatal outcomes were compared between mothers who did and did not receive antenatal corticosteroids. Logistic regression variables included birth weight, sex, race, amnionitis, tocolytic therapies, mode of delivery, and surfactant use. RESULTS: Two hundred fourteen of the 378 infants whose mothers had preterm rupture of membranes were deemed potentially viable; 62 of these mothers received antenatal steroids and 152 did not. Groups were similar with respect to gestational age, birth weight, race, amnionitis, and delivery mode. Women who received antenatal steroids were more likely to have received tocolysis (P <.001). Univariate and regression analyses controlling for multiple confounders confirmed no neonatal benefits of maternal corticosteroid use. CONCLUSIONS: Corticosteroid treatment in women with preterm rupture of membranes was of no apparent benefit to neonates weighing </=1000 g.

Adrenal Cortex Hormones↗